Zobrazeno 1 - 3
of 3
pro vyhledávání: '"SERC trial group"'
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations
Externí odkaz:
https://doaj.org/article/c13f72211bf3423f91ce4844474dd13c
Autor:
Gilles Houvenaeghel, Houssein El Hajj, Julien Barrou, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, François Desmons, Agnès Tallet, Jean-Marie Boher, the SERC Trial Group
Publikováno v:
Cancers, Vol 12, Iss 10, p 2924 (2020)
Many trials confirmed the safety of omitting axillary dissection in the selected patients treated for early breast cancer. The external validity of these trials is questionable. Our study aimed to evaluate the accuracy of the French population repres
Externí odkaz:
https://doaj.org/article/f764c33a8dd74df0881e4754e6678e12
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Christine Tunon de Lara, Pierre Gimbergues, Tristan Gauthier, Christelle Faure-Virelizier, Véronique Vaini-Cowen, Stéphane Lantheaume, Claudia Regis, Emile Darai, Vivien Ceccato, Gauthier D’Halluin, Francesco Del Piano, Richard Villet, Eva Jouve, Bassoodéo Beedassy, Pierrick Theret, Philippe Gabelle, Cécile Zinzindohoue, Pierre Opinel, Catherine Marsollier-Ferrer, Caroline Dhainaut-Speyer, Pierre-Emmanuel Colombo, Eric Lambaudie, Agnès Tallet, Jean-Marie Boher, Others investigators (SERC trial group)
Publikováno v:
BMC Cancer
BMC Cancer, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, BioMed Central, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Cancer, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, BioMed Central, 2018, 18, pp.1153. ⟨10.1186/s12885-018-5053-7⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trials to vali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b489f553d5abce5b605db53daf00b9
https://hal.sorbonne-universite.fr/hal-01980063/document
https://hal.sorbonne-universite.fr/hal-01980063/document